Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain
Post-mastectomy Pain Syndrome

About this trial
This is an interventional treatment trial for Post-mastectomy Pain Syndrome
Eligibility Criteria
Inclusion Criteria: Female patient 20-65yrs underwent surgery for breast cancer Pain duration of more than 6 months Pain is moderate to severe pain (visual analog scale [VAS] ≥ 4 cm), Pain described as a refractory one that is defined as pain for which classic biomedical therapy has proven ineffective Pain is of positive neuropathic character as detected by the grading system for neuropathic pain (GSNP), with a score of 3 or 4 Exclusion Criteria: Refusal of the patient Recent myocardial infarction Anti-coagulated patients or coagulopathy (evaluate risk/benefit ratio) Glaucoma Pre-existing counter lateral nerve palsy Severe emphysema Cardiac conduction block Local and systemic sepsis Local anatomical distortion (which may render the block technically difficult or hazardous. Psychiatric illness.
Sites / Locations
- NCIEgypt IRB officeRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Stellate ganglion block with alcohol injection
thermal RF neurolysis of Stellate ganglion
Stellate ganglion block with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy.
Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance